Thymoma Type B3

3 registered clinical trials studyying Thymoma Type B3.

Status	Trial	Sponsor	Phase
Completed	Combination of Pembrolizumab and Lenvatinib, in Pre-treated Thymic CArcinoma paTIents NCT04710628	MedSIR	Phase 2
Unknown	Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) NCT03134118	European Organisation for Research and Treatment of Cancer - EORTC	Phase 2
Completed	Regorafenib in Patients With Metastatic Solid Tumors Who Have Progressed After Standard Therapy NCT02307500	Istituto Clinico Humanitas	Phase 2